Learn if You Have a Claim Against Gambro

Gambro Da Vita Kidney Dialysis Machines Under Investigation Lawyers are actively investigating claims of high fever and hospitalizations leading to serious illness or death associated with use of Gambro Da Vita Kidney Dialysis machines.
Please detail any medical problems you associate to the DaVita Dialysis machines:

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Canadian Class Action Filed Against Lakeridge Health Corporation and Brooklin Medical Centre Alleging Negligent Exposure to TB

A class action has been filed against Lakeridge Health Corporation and the Brooklin Medical Centre, Inc., on behalf of all persons who were negligently exposed to tuberculosis by their contact with a tuberculosis carrier at any of the Ontario, Canada, facilities between February 1 and October 23, 2003, and who were later contacted by any public health authority or the defendants and advised that they might have contracted TB, or who actually contracted the disease. The action seeks $200 million in compensatory damages, and $20 million and punitive damages.

New Case Filed Against Beverly Enterprises, Details Not Yet Available

A class action lawsuit has been filed in US District Court against Arkansas based Beverly Enterprises, Inc. d/b/a Beverly Healthcare The case involves violations of contract law. No additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available.

Gateway Medical Center Seeks Dismissal from Class Action

A class action complaint alleging Gateway Regional Medical Center in Granite City, Illinois inflated charges for uninsured patients will be heard on the hospital's motion to dismiss on Sept. 26. Circuit Judge Daniel Stack will hear the case in place of the retired Judge Philip Kardis. Kimberly Chronister, Lisa Golino, Julia Holman, Linda Hughes, and Robert Orasco accuse the hospital of charging unfair and unreasonable prices for medical care. The plaintiffs all reside in Illinois.

Willed Body Programs at Tulane and LSU-Shreveport under Investigation for Alleged Mistreatment of Human Remains

Kahn Gauthier Swick is investigating claims that the Tulane University Willed Body Program, and possibly the Willed Body Program at LSU-Shreveport, has allowed human remains under its care to be treated disrespectfully, and in a manner that would horrify the casual onlooker. If you have a loved one whose body was donated to Tulane, please contact Kahn Gauthier for more information.

Stockholders Prevail Against PHP HealthCare Corporation in $4.5 Million Settlement

The parties have reached a tentative $4.5 million settlement in several actions filed against PHP Healthcare Corporation and certain of its officers and directors by stockholders who purchased the company's common stock between July 27, 1995, and November 19, 1998. Persons eligible to participate in the settlement must file a proof of claim postmarked no later than May 13, 2004.

FTC Claims Biotape is the Latest in Medical Quackery

An administrative proceeding has been filed against Smart Inventions, Inc., a California-based direct response TV company, and its Chief Operating Officer, Jon D. Nokes, by the Federal Trade Commission on behalf of persons who purchased “Biotape,” a tape-like substance promoted to treat or cure severe pain. The action alleges that there is no substantial evidence that the product relieves pain, and that the advertisements violate the FTC Act because they are false and misleading.